WO2013177262A2 - Methods for diagnosing cognitive impairment - Google Patents

Methods for diagnosing cognitive impairment Download PDF

Info

Publication number
WO2013177262A2
WO2013177262A2 PCT/US2013/042193 US2013042193W WO2013177262A2 WO 2013177262 A2 WO2013177262 A2 WO 2013177262A2 US 2013042193 W US2013042193 W US 2013042193W WO 2013177262 A2 WO2013177262 A2 WO 2013177262A2
Authority
WO
WIPO (PCT)
Prior art keywords
body temperature
canine
cognitive impairment
measuring
measured
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2013/042193
Other languages
French (fr)
Inventor
Brian M. ZANGHI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nestec SA
Original Assignee
Nestec SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec SA filed Critical Nestec SA
Publication of WO2013177262A2 publication Critical patent/WO2013177262A2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61DVETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D99/00Subject matter not provided for in other groups of this subclass
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/01Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/16Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
    • A61B5/165Evaluating the state of mind, e.g. depression, anxiety
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2503/00Evaluating a particular growth phase or type of persons or animals
    • A61B2503/40Animals

Definitions

  • the invention relates generally to methods for diagnosing cognitive impairment in canines and particularly to methods for diagnosing cognitive impairment in canines by measuring body temperature.
  • Canine Cognitive Dysfunction Syndrome is the age related deterioration of cognitive abilities.
  • Canines with CCDS exhibit various behavioral disorders. For example, they may not respond to their name or familiar commands, may get lost or confused even in familiar surroundings, may no longer greet or respond to their owners or visitors, may exhibit diminished daytime activity, may walk in circles, may shun affection, and may lose bladder or bowel control.
  • Early detection of cognitive im airment will help healthcare professionals and pet owners make informed choices about reducing the risk of developing CDS in their canines.
  • Nutritional supplementation has a potentially valuable role to play in maximizing the benefit of therapy in terms of increasing the canines' quality of life. Key to this benefit is the early detection of cognitive impairment thereby enabling canines to receive the most appropriate care.
  • an object of the present invention to provide methods for diagnosing cognitive impairment in canines.
  • canine means any canine susceptible to or suffering from cognitive impairment.
  • dog means all domesticated canines, including working dogs and pet dogs.
  • sensenior means a canine of an age having an increased risk for age-related disease, e.g., cognitive impairment, but may or may not. have obvious physical or behavioral characteristics of aging. For example, for dogs, “senior” means an age of from about 7 years to about 1 1 years, or older,
  • j0012 ⁇ The term "comparable control canine” means a canine of the same species and type or an individual canine evaluated at two different times.
  • the term "diagnosing" means determining if a canine is suffering from or predicting If the canine is likely to developing cognitive impairment.
  • ranges are used herein in shorthand, so as to avoid having to list and describe each and every value within, the range. Any appropriate value within die range can be selected, where appropriate, as the upper value, lower value, or the terminus f the range.
  • the invention provides methods for diagnosing cognitive impairment in a canine.
  • the methods comprise measuring a first body temperature of the canine from about 0.5 to about 3 hours after waking; measuring a second body temperature of the canine from about 8 to about 13 hours after measuring the first body temperature; and determining that the canine is cogmtively impaired if the first body temperature is less than 0.6°C lower than the second body temperature.
  • both the first temperature and the second temperature are less than 38°C.
  • the first body temperature of the canine is measured from 0.5 to about 3 hour after waking; preferably from about 1 to about 2.5 hours after waking; more preferably from about 1 to about 2 hours after waking.
  • the second body temperature is measured at about 8 to about 13 hours after measuring the first bod temperature, preferably from about 9 to about 12 hours after measuring the first body temperature, more preferably from about 9 to about 1 1 hours after measuring the first body temperature,
  • the invention provides methods for diagnosing cognitive impairment i - canine.
  • the methods comprising measuring a first body temperature of the canine at about 6 am to about 1.1 am; measuring a second body temperature of the canine at about 4 pm to about. 1 1 pm; and determining that the canine is eogmtively impaired if the first body temperature is less than 0.6°C lower than the second body temperature.
  • both the first temperature and the second temperature are less than
  • the first body temperature of the canine is measured, at about 6 am to about 1 1 am. preferably at about 7 am to 10 am, more preferably at about 8 am to 10 am.
  • the second body temperature is measured at about 4 pm to about 1 1 pm, preferably at about 5 pm to about 11 pm, more preferably at about 6 pm to about. 8 pm.
  • the second body temperature is measured at about 7 pm.
  • the canine is a dog.
  • the dog is a senior dog.
  • the senior dog is 9 or more years of age
  • The. inventions are based upon the discovery that body temperature in cognitive!y impaired eanin.es is lower compared to body temperature in comparable control canines that are not cognitive))' impaired. In addition, it was discovered that the range of daily body temperature in cogmiively impaired canines is lower compared to comparable control canines that are not cognitive! ⁇ 1 impaired.
  • the invention allows veterinary and other clinicians to use body temperature to determine whether the canine is likely to develop cognitive impairment or is suffering from cognitive impairment and whether there is a need for further diagnostics or treatments. Having established the need for further diagnostics or treatments using the simple method for the invention, the cost and. risk of such further more expensive or invasive diagnostics or treatments are justified.
  • HPM High Performing Memory
  • Group C Moderate Performing Memory (MPM), N ::: 24
  • DNMP testing was carried out at. baseline and again after 45 days. Dogs were tested on three-choice varDNMP for 10 baseline days, and for 14 days during retest Ail DNMP testing will consist of variable-delayed testing in which delays of 20 and 90 seconds will occur with equal frequency over the 12 test trials per day, resulting in 60 trials for each delay during baseline and 84 trials for each delay during retest. The delays will occur randomly within the test sessions, with the constraint that, each delay will occur on exactly 6 trials.
  • Core body temperature was measured based on rectal temperature collected during the baseline phase and end-of-study phase. Core body temperature readings were recorded at 8AM ( ⁇ 30rains), 10 AM ( ⁇ 30mins k 1 PM ( ⁇ 30mins), 3 PM ⁇ 30mins). 7PM ( ⁇ SOmms). and 1 :30 AM ( ⁇ I Smms ).

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Educational Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Developmental Disabilities (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Social Psychology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Fodder In General (AREA)

Description

METHODS FOR DIAGNOSING COGNITIVE IMPAIRMENT
CROSS REFERENCE TO RELATED APPLICATIONS
[0001] This application claims priority to U.S. Provisional Application Serial No. 61 /651 182 .filed May 24, 2012, the disclosure of which is incorporated herein by this reference,
BACKGROU D OF THE I NVENTION
Field of the invention
{'00021 The invention relates generally to methods for diagnosing cognitive impairment in canines and particularly to methods for diagnosing cognitive impairment in canines by measuring body temperature.
Description of Related Art
[00031 Aged, or aging canines frequently suffer some degree of cognitive impairment. Canine Cognitive Dysfunction Syndrome (CCDS) is the age related deterioration of cognitive abilities. Canines with CCDS exhibit various behavioral disorders. For example, they may not respond to their name or familiar commands, may get lost or confused even in familiar surroundings, may no longer greet or respond to their owners or visitors, may exhibit diminished daytime activity, may walk in circles, may shun affection, and may lose bladder or bowel control. Early detection of cognitive im airment will help healthcare professionals and pet owners make informed choices about reducing the risk of developing CDS in their canines. Nutritional supplementation has a potentially valuable role to play in maximizing the benefit of therapy in terms of increasing the canines' quality of life. Key to this benefit is the early detection of cognitive impairment thereby enabling canines to receive the most appropriate care.
[0004} Body temperatures cycle up and down throughout the day as part of the cireadian rhythm. Canines with cognitive impairment typically experience an alteration in their cireadian rhythms.
[0005} There remains a need for diagnosing cognitive impairment in canines to provide the most appropriate and effective level of treatment. The use of body temperature as an indicator of cognitive impairment provides a simple and convenient method lor veterinary clinicians and pet- owners. Such treatment will improve the canine's quality of life. The present invention satisfies this need.
SUMMARY OF THE INVENTIO [0006] It Is, therefore, an object of the present invention to provide methods for diagnosing cognitive impairment in canines.
|0007| This and other objects are achieved using methods for diagnosing cognitive impairment in a canine that involve measuring a fi st body temperature of the canine from about 0.5 to about 3 hours after waking; measuring a second body temperature of the canine from about 8 to about. 33 hours after measuring the first body temperature; and determining that the canine is cognitive!. impaired if the first body temperature is less than 0.6oC lower than the second body temperature.
[0008] Other and further objects, features, and advantages of the present invention will be readily apparent to those skilled in the art
DETAILED DESCRIPTION OF THE INVEN ION
Definitions:
|0009j The term '"canine"' means any canine susceptible to or suffering from cognitive impairment.
[001.0} The term "dog"' means all domesticated canines, including working dogs and pet dogs. |0 t I) The term "senior" means a canine of an age having an increased risk for age-related disease, e.g., cognitive impairment, but may or may not. have obvious physical or behavioral characteristics of aging. For example, for dogs, "senior" means an age of from about 7 years to about 1 1 years, or older,
j0012{ The term "comparable control canine" means a canine of the same species and type or an individual canine evaluated at two different times.
|'00!3) The term "diagnosing" means determining if a canine is suffering from or predicting If the canine is likely to developing cognitive impairment.
[0014] As used herein, ranges are used herein in shorthand, so as to avoid having to list and describe each and every value within, the range. Any appropriate value within die range can be selected, where appropriate, as the upper value, lower value, or the terminus f the range.
[0015) As used herein, the singular form of a word includes the plural, and vice versa, unless the context clearly dictates otherwise. Thus, the references "a", "an", and "the" are generally inclusive of the plurals of the respective terms. For example, reference to "a method" includes a plurality of such "methods," Similarly, the words "comprise" "comprises", and "comprising" are to be interpreted inclusively rather than exclusively. Likewise the terms "include". "including" and "or" should all be construed io be inclusive, unless such a construction is clearly prohibited from the context,
10016 i The methods and compositions and other advances disclosed here are not limited to particular methodology, protocols, and reagents described herein because, as the skilled artisan will appreciate, they may vary. Further, the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to, and does not, limit the scope of that which is disclosed or claimed.
{'00.1.7] Unless defined otherwise, all technical and scientific terms, terms of art, and acronyms used herein have the meanings commonly understood by one of ordinary skill in the art in the field(s) of the invention, or in the fieid(s) where the term is used.
{001 Sj All patents, patent applications, publications, technical and/or scholarly articles, and other references cited or referred to herein are in their entirety incorporated herein by reference to the extent allowed by law. The discussion of those references is intended merely to summarize the assertions made therein. " o admission is made that, any such patents, patent applications, publications or references, or any portion thereof, are relevant, material, or prior art The right to challenge the accuracy and pertinence of any assertion of such patents, patent applications, publications, and other references as relevant, material, or prior art is specifically reserved.
The Invention
J.00I9J in one aspect the invention provides methods for diagnosing cognitive impairment in a canine. The methods comprise measuring a first body temperature of the canine from about 0.5 to about 3 hours after waking; measuring a second body temperature of the canine from about 8 to about 13 hours after measuring the first body temperature; and determining that the canine is cogmtively impaired if the first body temperature is less than 0.6°C lower than the second body temperature.
(0020] In one embodiment, both the first temperature and the second temperature are less than 38°C.
(00211 In various embodiments, the first body temperature of the canine is measured from 0.5 to about 3 hour after waking; preferably from about 1 to about 2.5 hours after waking; more preferably from about 1 to about 2 hours after waking.
[ 022| in various embodiments, the second body temperature is measured at about 8 to about 13 hours after measuring the first bod temperature, preferably from about 9 to about 12 hours after measuring the first body temperature, more preferably from about 9 to about 1 1 hours after measuring the first body temperature,
(0023 J in another aspect, the invention provides methods for diagnosing cognitive impairment i - canine. The methods comprising measuring a first body temperature of the canine at about 6 am to about 1.1 am; measuring a second body temperature of the canine at about 4 pm to about. 1 1 pm; and determining that the canine is eogmtively impaired if the first body temperature is less than 0.6°C lower than the second body temperature.
(0024] In one embodiment, both the first temperature and the second temperature are less than
38°C.
|0 25] in various embodiments, the first body temperature of the canine is measured, at about 6 am to about 1 1 am. preferably at about 7 am to 10 am, more preferably at about 8 am to 10 am. {0026 J In another embodiment, the second body temperature is measured at about 4 pm to about 1 1 pm, preferably at about 5 pm to about 11 pm, more preferably at about 6 pm to about. 8 pm. hi one embodiment, the second body temperature is measured at about 7 pm.
(0027| In various embodiments, the canine is a dog. In one embodiment, the dog is a senior dog. in another embodiment, the senior dog is 9 or more years of age,
(0028] The. inventions are based upon the discovery that body temperature in cognitive!y impaired eanin.es is lower compared to body temperature in comparable control canines that are not cognitive))' impaired. In addition, it was discovered that the range of daily body temperature in cogmiively impaired canines is lower compared to comparable control canines that are not cognitive!}1 impaired. The invention allows veterinary and other clinicians to use body temperature to determine whether the canine is likely to develop cognitive impairment or is suffering from cognitive impairment and whether there is a need for further diagnostics or treatments. Having established the need for further diagnostics or treatments using the simple method for the invention, the cost and. risk of such further more expensive or invasive diagnostics or treatments are justified.
EXAMPLES
(0029] The invention can be further illustrated by the following examples, although it will be understood that these examples are included merely for purposes of illustration and are not. intended to limit the scope of the invention unless otherwise specifically indicated. Example 1
003ft] Sixty (60) dogs ere selected from a pool of seventy dogs, which were at least eight years of age. The selection was based on memory performance using a variable dela non- matching to position task (varDNMP). First, the dogs were placed in three non-overlapping groups that were defined as:
Group A: High Performing Memory (HPM), N::: 12
Group B: Low Performing Memory (LPM). N";24
Group C: Moderate Performing Memory (MPM), N:::24
[0031 ] DNMP testing was carried out at. baseline and again after 45 days. Dogs were tested on three-choice varDNMP for 10 baseline days, and for 14 days during retest Ail DNMP testing will consist of variable-delayed testing in which delays of 20 and 90 seconds will occur with equal frequency over the 12 test trials per day, resulting in 60 trials for each delay during baseline and 84 trials for each delay during retest. The delays will occur randomly within the test sessions, with the constraint that, each delay will occur on exactly 6 trials.
[0032] Core body temperature was measured based on rectal temperature collected during the baseline phase and end-of-study phase. Core body temperature readings were recorded at 8AM (± 30rains), 10 AM (± 30mins k 1 PM (± 30mins), 3 PM {± 30mins). 7PM (± SOmms). and 1 :30 AM (± I Smms ).
(0033] To establish whether the varDNMP baseline groupings had different core body temperatures., the control canines from each of the three groups were compared during the baseline portion of the study. As detailed in Table 1, the LPM canines had mean core (rectal) body temperature readings thai were quantitatively lower at all 6 time points recorded within a 24 hour period compared to the HPM and MPM canines. Of particular importance was the 7 pm recording, which demonstrated the peak body temperature. LPM dogs had a 0.44"C lower body temperature at this peak time compared to HPM and MPM canines. Referring to Table 1 , the data shows that body temperature can be used to diagnose cognitive impairment, in canines.
Table !
Body Temperature Data of Control Dogs (N-36) Recorded at Multiple Times
During the Day of the Baseline Phase
8:00 AM 10:00 AM 1 :00 PM 3:00 PM 7:00 PM 1 :30 AM
Figure imgf000007_0001
[003 j In the specification, there have been disclosed typical preferred embodiments of the invention. Although specific terms are employed, they are used in a generic and descriptive sense only and not for purposes of limitation. The scope of the invention is set forth in the claims. Obviously many modifications and variations of the invention are possible in light of the above teachings. It is therefore to be understood that within the scope of the appended claims, the invention may be practiced otherwise than as specifically described.

Claims

CLAIMS What is claimed is:
1 . A method for diagnosing cognitive impairment in a canine comprising
a. measuring a first body temperature of the canine from about. 0.5 to about 3 hours after waking:
b. measuring a second body temperature of the canine from about 8 to about 13 hours after measuring the first, body tempera lure; and
c. determining that the canine is cognitively impaired if the first, body temperature is less than 0.6°C lower than the second body temperature.
2. The method of claim 1 wherein the first body temperature of the canine is measured from about 1 to about 2.5 hours after waking.
3. The method, of claim 1 wherein the first body temperature of the canine is measured from about 1 to about 2 hours after waking.
4. The method of claim 1 wherein the second body temperature of the canine is measured from about 9 to about 12 hours after measuring the first body temperature.
5. The method of claim. 1 wherein the second body temperature of the canine is measured from about 9 to about J 1 hours after measuring the first body temperature.
6. The method of claim 1 wherein the canine is a dog.
7. The method of claim 6 wherein the dog is a senior dog.
8. The method of claim 7 wherein the senior dog is 9 or more years of age.
9. The method of claim 1 wherein both the first temperature and the second temperature are less than ?>8''<.\
10. A method for diagnosing cognitive impairment in a canine comprising
a. measuring a first body temperature of the canine at about 6 am to about 11 am;
b, .measuring a second body temperature of the canine at. about 4 prn to about 1 1 pm; and
e. determining that the canine is cognitively impaired if the first body temperature is less than Q.ir'C lower than the second body temperature
1 L The method of claim 10 wherein the first body temperature of the canine is measured at about 7 am to about 10 am.
12. T he method of ciaini 10 wherein the first body temperature of the canine is measured at about 8 am to about 10 am.
13. The method of claim 1.0 wherein the second body temperature of the canine is measured at about 5 pm to about i i pm.
14. The method of claim 10 wherein the second body temperature of the canine is measured at about 6 pm to about 8 pm.
15. The method of claim 10 wherein the second body temperature of the canine is measured at. about 7 pm.
16. The method of claim 10 wherein the canine is a dog.
17. The method of claim 16 wherein the dog is a senior dog.
18. The method of claim 1 7 wherein the senior dog Is 9 or more years of age.
1 (>. The method of claim 10 wherein both the first temperature and the second temperature are less than 38 °C
PCT/US2013/042193 2012-05-24 2013-05-22 Methods for diagnosing cognitive impairment Ceased WO2013177262A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261651182P 2012-05-24 2012-05-24
US61/651,182 2012-05-24

Publications (1)

Publication Number Publication Date
WO2013177262A2 true WO2013177262A2 (en) 2013-11-28

Family

ID=48539442

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2013/042193 Ceased WO2013177262A2 (en) 2012-05-24 2013-05-22 Methods for diagnosing cognitive impairment

Country Status (3)

Country Link
US (1) US20130317387A1 (en)
AR (1) AR093752A1 (en)
WO (1) WO2013177262A2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5191896A (en) * 1991-06-28 1993-03-09 Medoc Ltd. Apparatus for measuring threshold sensitivity to a stimulus
US6675744B1 (en) * 2000-06-02 2004-01-13 Michele Levan Mood collar for pets
KR100455286B1 (en) * 2002-01-11 2004-11-06 삼성전자주식회사 Method and apparatus for understanding the condition of animal using acquisition and analysis of physiological signal of the animal

Also Published As

Publication number Publication date
US20130317387A1 (en) 2013-11-28
AR093752A1 (en) 2015-06-24

Similar Documents

Publication Publication Date Title
Oakley et al. Temperature-and age-dependent seizures in a mouse model of severe myoclonic epilepsy in infancy
Favrot et al. A prospective study on the clinical features of chronic canine atopic dermatitis and its diagnosis
Gyles et al. Advancing preclinical chronic stress models to promote therapeutic discovery for human stress disorders
Lino-de-Oliveira et al. Structure of the rat behaviour in the forced swimming test
Arts et al. The impact of transportation on physiological and behavioral parameters in Wistar rats: implications for acclimatization periods
Denham et al. Repetitive behaviour in kennelled domestic dog: Stereotypical or not?
Krafft et al. Correlation between subacute sensorimotor deficits and brain edema in two mouse models of intracerebral hemorrhage
Liuzzi et al. Development of movement-related intracortical inhibition in acute to chronic subcortical stroke
Leenaars et al. A new automated method for rat sleep deprivation with minimal confounding effects on corticosterone and locomotor activity
BRPI0413556A (en) amyloid accumulating disease probes, amyloid dyeing agents, drugs for treatment and prophylaxis of accumulated amyloid diseases, and neurofibrillary tangle diagnostic probes and neurofibrillary tangle dyeing agents
Yang et al. Foraging activity is reduced in a mouse model of depression
Rodriguez et al. A simplified procedure for the quantitative measurement of neurological deficits after forebrain ischemia in mice
RU2016149127A (en) CALIBRATING ANALYTES LEVEL USING A BASIC ANALYTES LEVEL
Velazquez-Sanchez et al. The development of compulsive coping behaviour is associated with a downregulation of Arc in a Locus Coeruleus neuronal ensemble
Herzberg et al. Animal models of chronic pain. Are naturally occurring diseases a potential model for translational research?
Holtby et al. Integrative genomics analysis highlights functionally relevant genes for equine behaviour
Ren et al. Behavioral genetic studies in rats
Montesinos et al. Egg white specific IgE levels in serum as clinical reactivity predictors in the course of egg allergy follow‐up
WO2013177262A2 (en) Methods for diagnosing cognitive impairment
Woelfel et al. Presumed pituitary apoplexy in 26 dogs: clinical findings, treatments, and outcomes
Dreschel et al. Advancing the social neuroscience of human-animal interaction: The role of salivary bioscience.
Griffin Diagnosis of canine atopic dermatitis
Kay et al. Mice from lines selectively bred for voluntary exercise are not more resistant to muscle injury caused by either contusion or wheel running
Moghekar et al. Con: Alzheimer's disease and circadian dysfunction: chicken or egg?
Egebjerg et al. Introduction of novel objects to the home cage of mice repeatedly disturbs sleep for seven days with minimal stress induction

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13726392

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13726392

Country of ref document: EP

Kind code of ref document: A2